Searching for Clarity: A Primer on Medical Studies. Gina Kolata. The New York Times. 2008-09-29
URL: http://www.nytimes.com/2008/09/30/health/30stud.html (Requires free registration)
MMR row doctor spreads fear to US. John Harlow. The Times. 2008-09-28
URL: http://www.timesonline.co.uk/tol/news/uk/health/article4837798.ece
Controversial Metal Poisoning Therapy Under Investigation After Possible Deaths. NBC6.net 2008-09-30.
URL: http://www.nbc6.net/health/17591094/detail.html
Government probes chelation-heart disease study. Marilynn Marchione. AP. 2008-09-26
URL: http://ap.google.com/article/ALeqM5jI1k5Hrp22Ind9eS3jbWYHfJh_BQD93E17L00
Related: Atwood KC, Woeckner E, Baratz RS, Sampson WI. Why the NIH Trial to Assess Chelation Therapy (TACT) Should Be Abandoned. Medscape J Med 2008;10(5):115. Accessed on 2008-06-11 at: http://journal.medscape.com/viewarticle/570625 (Requires free registration)
Index of TACT study documents and related materials on the CIRCARE web site: http://www.circare.org/tact/tactindex.htm
Index of tables of information related to the TACT on the CIRCARE web site: http://www.circare.org/tact/tact_tableindex.htm
TACT Portal Site Archive on the Chelationwatch web site courtesy of Dr. Steve Barrett: http://www.chelationwatch.org/research/tact/index.html [Ed. The public could access the heretofore password protected study web site at http://www.tactnih.com in August; for reasons unknown there was no prompt for login or password.]
Enrollment stopped in NIH-funded trial studying chelation therapy for treatment of CAD. Michael O'Riordan. Medscape News. 2008-09-24: http://test.theheart.org/article/907501.do
ACAM Supports NIH Decision to Suspend TACT Trial. American College for Advancement in Medicine Press Release. Undated. Accessed on 2008-09-27 at: http://tinyurl.com/4ehtpg
ACAM Affirms Commitment to Trial to Assess Chelation Therapy. American College for Advancement in Medicine Press Release. 2008-05-27. Accessed on 2008-09-27 at: http://tinyurl.com/4umdaq
Public Health Advisory and Information on Edetate Disodium (marketed as Endrate and generic products). U.S. Food and Drug Administration. 2008-01-16. Accessed on 2008-09-27 at: http://www.fda.gov/cder/drug/infopage/edetate_disodium/default.htm
National Supply Service Center (NSSC) Important Notice Market Withdrawal. Recall: 2008-008. Class of Recall: Not Yet Classified-Hospital Level. Supplier: Hospira Worldwide Inc. #00108. Product Description: Endrate AMP 150mg 20ml 25's. 2008-01-16. Accessed on 2008-03-29 at: http://www.ihs.gov/NonMedicalPrograms/NSSC/index.asp?module=alerts&opt=2008-008
Docket No. FDA-2008-N-03211 Hospira, Inc., et al.; Withdrawal of Approval of One New Drug Application and Two Abbreviated New Drug Applications. FR Doc E8-1373 Filed 6-11-08. Accessed on 2008-09-25 at: http://www.fda.gov/OHRMS/DOCKETS/98fr/FDA-2008-N-0321-nwl.pdf
Charlatans to the Rescue. Linda Seebach. Wall Street Journal. 2008-09-23
URL: http://online.wsj.com/article/SB122212979072465559.html
US researchers call off controversial autism study. Carla K. Johnson. AP. 2008-09-17
URL: http://apnews.myway.com/article/20080917/D938P9RG3.html
Last Updated: 2009-02-01
If you find the information on this page helpful please support CIRCARE with a tax-deductible contribution today. Because CIRCARE doesn't accept funds from pharmaceutical or medical device manufacturers, we depend on contributions from individuals like you to help us advocate for meaningful protection of human subjects in research. Donating online with PayPal is quick and easy. Find out more on our Support page
All material on this site © CIRCARE Incorporated (2002-2005) or as indicated. Single copies can be downloaded for personal education. Adobe® Reader :: ::
